Literature DB >> 18855814

Guidelines for research on drugged driving.

J Michael Walsh1, Alain G Verstraete, Marilyn A Huestis, Jørg Mørland.   

Abstract

AIMS: A major problem in assessing the true public health impact of drug-use on driving and overall traffic safety is that the variables being measured across studies vary significantly. In studies reported in a growing global literature, basic parameters assessed, analytical techniques and drugs tested are simply not comparable due to lack of standardization in the field. These shortcomings severely limit the value of this research to add knowledge to the field. A set of standards to harmonize research findings is sorely needed. This project was initiated by several international organizations to develop guidelines for research on drugged driving.
METHODS: A September 2006 meeting of international experts discussed the harmonization of protocols for future research on drugged driving. The principal objective of the meeting was to develop a consensus report setting guidelines, standards, core data variables and other controls that would form the basis for future international research. A modified Delphi method was utilized to develop draft guidelines. Subsequently, these draft guidelines were posted on the internet for global review, and comments received were integrated into the final document.
RESULTS: The Guidelines Document is divided into three major sections, each focusing upon different aspects of drugged driving research (e.g. roadside surveys, prevalence studies, hospital studies, fatality and crash investigations, etc.) within the critical issue areas of 'behavior', 'epidemiology' and 'toxicology'. The behavioral section contains 32 specific recommendations; (2) epidemiology 40 recommendations; and (3) toxicology 64 recommendations.
CONCLUSIONS: It is anticipated that these guidelines will improve significantly the overall quality of drugged driving research and facilitate future cross-study comparisons nationally and globally.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18855814      PMCID: PMC2690607          DOI: 10.1111/j.1360-0443.2008.02277.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  3 in total

Review 1.  Drugs and driving.

Authors:  J Michael Walsh; Johan J de Gier; Asbjørg S Christopherson; Alain G Verstraete
Journal:  Traffic Inj Prev       Date:  2004-09       Impact factor: 1.491

Review 2.  Driving under the Influence of Non-Alcohol Drugs.

Authors:  J Mørland
Journal:  Forensic Sci Rev       Date:  2000-01

3.  The incidence of drugs in drivers killed in Australian road traffic crashes.

Authors:  Olaf H Drummer; Jim Gerostamoulos; Helen Batziris; Mark Chu; John R M Caplehorn; Michael D Robertson; Philip Swann
Journal:  Forensic Sci Int       Date:  2003-07-08       Impact factor: 2.395

  3 in total
  32 in total

1.  Prevalence of alcohol and other drugs in fatally injured drivers.

Authors:  Joanne E Brady; Guohua Li
Journal:  Addiction       Date:  2012-08-20       Impact factor: 6.526

2.  Effect of chronic opioid therapy on actual driving performance in non-cancer pain patients.

Authors:  Markus B Schumacher; Stefan Jongen; Anja Knoche; Frank Petzke; Eric F Vuurman; Mark Vollrath; Johannes G Ramaekers
Journal:  Psychopharmacology (Berl)       Date:  2017-02-12       Impact factor: 4.530

3.  Prevalence of Self-Reported Prescription Drug Use in a National Sample of U.S. Drivers.

Authors:  Tara Kelley-Baker; Geetha Waehrer; Robin A Pollini
Journal:  J Stud Alcohol Drugs       Date:  2017-01       Impact factor: 2.582

4.  Oral fluid with three modes of collection and plasma methamphetamine and amphetamine enantiomer concentrations after controlled intranasal l-methamphetamine administration.

Authors:  Matthew N Newmeyer; Marta Concheiro; Jose Luiz da Costa; Ronald Flegel; David A Gorelick; Marilyn A Huestis
Journal:  Drug Test Anal       Date:  2015-03-18       Impact factor: 3.345

5.  MDMA and metabolite disposition in expectorated oral fluid after controlled oral MDMA administration.

Authors:  Allan J Barnes; Karl B Scheidweiler; Erin A Kolbrich-Spargo; David A Gorelick; Robert S Goodwin; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2011-10       Impact factor: 3.681

6.  Pharmacokinetics of cocaine and metabolites in human oral fluid and correlation with plasma concentrations after controlled administration.

Authors:  Karl B Scheidweiler; Erin A Kolbrich Spargo; Tamsin L Kelly; Edward J Cone; Allan J Barnes; Marilyn A Huestis
Journal:  Ther Drug Monit       Date:  2010-10       Impact factor: 3.681

7.  Validity and reliability of a driving simulator for evaluating the influence of medicinal drugs on driving performance.

Authors:  Mari Iwata; Kunihiro Iwamoto; Iwao Kitajima; Takasuke Nogi; Koichi Onishi; Yu Kajiyama; Izumi Nishino; Masahiko Ando; Norio Ozaki
Journal:  Psychopharmacology (Berl)       Date:  2020-11-24       Impact factor: 4.530

8.  Oral fluid cocaine and benzoylecgonine concentrations following controlled intravenous cocaine administration.

Authors:  Kayla N Ellefsen; Marta Concheiro; Sandrine Pirard; David A Gorelick; Marilyn A Huestis
Journal:  Forensic Sci Int       Date:  2016-01-22       Impact factor: 2.395

9.  A new ultraperformance-tandem mass spectrometry oral fluid assay for 29 illicit drugs and medications.

Authors:  Marilyn A Huestis
Journal:  Clin Chem       Date:  2009-10-15       Impact factor: 8.327

10.  Oral fluid and plasma 3,4-methylenedioxymethamphetamine (MDMA) and metabolite correlation after controlled oral MDMA administration.

Authors:  Nathalie A Desrosiers; Allan J Barnes; Rebecca L Hartman; Karl B Scheidweiler; Erin A Kolbrich-Spargo; David A Gorelick; Robert S Goodwin; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2013-03-08       Impact factor: 4.142

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.